FOMC minutes; Delta, PepsiCo to report; gold retreats - what’s moving markets
FOSTER CITY, Calif. - Qualys, Inc. (NASDAQ:QLYS), a cybersecurity company with a market capitalization of $4.76 billion and impressive gross profit margins of 81.84%, announced Wednesday that its Government Platform has received FedRAMP High Authorization, sponsored by the U.S. Drug Enforcement Agency. According to InvestingPro data, the company maintains a strong financial health rating and holds more cash than debt on its balance sheet.
The authorization represents the most rigorous security level within the Federal Risk and Authorization Management Program, aligning with NIST 800-53 High Impact controls and designed for handling sensitive, unclassified government data.
The Qualys Government Platform provides federal agencies with a unified solution for vulnerability management, compliance, endpoint detection and response, asset inventory, policy enforcement, and web application security, with cloud-native application protection coming soon.
"Achieving FedRAMP High Authorization underscores our significant investment in best-in-class security and reaffirms our commitment as a trusted partner in advancing the U.S. Federal Government’s mission to strengthen cybersecurity," said Sumedh Thakar, president and CEO of Qualys.
The authorization positions Qualys among a select group of cybersecurity vendors offering comprehensive security solutions at the FedRAMP High level, according to the company’s press release statement.
The platform aims to address challenges faced by federal agencies dealing with limited staff and fragmented security tools by providing integrated visibility and control across their risk surface.
Qualys Government Cloud is now available on the FedRAMP marketplace, the company stated.
In other recent news, Qualys reported impressive financial results for the second quarter of 2025, surpassing Wall Street expectations. The company achieved an earnings per share of $1.68, beating the forecast of $1.47, and reported revenue of $164.1 million, exceeding the anticipated $161.24 million. Following these results, several analyst firms adjusted their price targets for Qualys. Scotiabank raised its price target to $150, maintaining a Sector Perform rating, citing the company’s revenue and earnings success. DA Davidson also increased its target to $135 while keeping a Neutral rating, noting a significant EBITDA beat and an 8% year-over-year growth in current calculated billings. Jefferies raised its price target to $150, describing the results as "better than feared" with a revenue beat of $2.9 million. These developments highlight the positive performance of Qualys in the recent quarter.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.